SCHEMBL15748809

SCHEMBL15748809

CCOC(=O)c1nnc2c(-c3ccc(Cl)cc3)c(C)nn2c1C(=O)OCC

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.81
THRB P10828 1/20 0.61
KDM4E B2RXH2 4/20 0.59
ALDH1A1 P00352 2/20 0.59
HPGD P15428 1/20 0.59
TDP1 Q9NUW8 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
TARBP2 Q15633 1/20 0.46
GAA P10253 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
GPR55 Q9Y2T6 1/20 0.45
CYP19A1 P11511 1/20 0.45
TSHR P16473 1/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
ELANE P08246 1/20 0.44
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
HTT P42858 1/20 0.43
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13977289 0.90 MAPT (1.00) MAPTTHRBKDM4EALDH1A1HPGD
SCHEMBL15748843 0.88 MAPT (0.64) MAPTTHRBKDM4EALDH1A1HPGD
SCHEMBL15748870 0.82 MAPT (0.85) MAPTTHRBKDM4EALDH1A1HPGD
SCHEMBL15748845 0.81 MAPT (0.55) MAPTTHRBKDM4EALDH1A1HPGD
SCHEMBL13977659 0.81 MAPT (0.80) MAPTTHRBKDM4EALDH1A1HPGD
SCHEMBL15748874 0.79 MAPT (0.81) MAPTTHRBKDM4EALDH1A1HPGD
SCHEMBL13977292 0.79 MAPT (0.80) MAPTTHRBKDM4EALDH1A1HPGD
SCHEMBL15748787 0.78 MAPT (0.62) MAPTTHRBKDM4EALDH1A1HPGD
SCHEMBL15748795 0.78 MAPT (0.78) MAPTTHRBKDM4EALDH1A1HPGD
SCHEMBL15502378 0.77 MAPT (0.78) MAPTTHRBKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9676779-B2 Small molecule CFTR correctors DISCOVERYBIOMED, INC. (US) 2017-06-13 US disclosed
US-9676779-B2 Small molecule CFTR correctors DISCOVERYBIOMED, INC. (US) 2017-06-13 US disclosed
US-20150299206-A1 SMALL MOLECULE CFTR CORRECTORS DISCOVERYBIOMED, INC. (US) 2015-10-22 US disclosed
US-20150299206-A1 SMALL MOLECULE CFTR CORRECTORS DISCOVERYBIOMED, INC. (US) 2015-10-22 US disclosed
WO-2014081820-A1 SMALL MOLECULE CFTR CORRECTORS DISCOVERYBIOMED, INC. (US) 2014-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150299206-A1 SMALL MOLECULE CFTR CORRECTORS CFTR, CLCN2, SLC26A4 MAPT 4258/4885THRB 2036/4885KDM4E 4245/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.